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Summary
Quorumsensing (QS) regulates the production of viru-
lence factors and the maturation of biofilms in many
bacteria, including Pseudomonas aeruginosa. The
QS cascade is activated by the interaction of bacterial
signaling molecules, called autoinducers (AIs), with
their corresponding regulatory proteins. Here, we re-
port a series of studies to define the stereochemical
preferences of synthetic agonists and perform dock-
ing studies to understand the microenvironment of
the binding site in P. aeruginosa QS regulators. One
of the key findings of thiswork is that the ring structure
and the absolute and relative stereochemistries of the
amide andhydroxyl groupsdictate the agonist activity.
This study aids in determining important structural
and stereochemical characteristics necessary for in-
teractionwith theQS regulatory proteins, thus expand-
ing our understanding of their inducer binding sites.
Introduction
Pseudomonas aeruginosa is an opportunistic pathogen
and is a common cause of infections in immunocompro-
mised individuals and individuals with cystic fibrosis [1].
Expression of genes that produce virulence factors such
as alkaline protease, elastase, exotoxin A, rhamnolipids,
and pyocyanin is governed by the response to the cell
density that is monitored by a mechanism known as quo-
rum sensing (QS) [2–5]. Biofilm formation is also a major
contributor to the virulence causing persistent infections
in lungs of cystic fibrosis patients, in which the regulation
of mature biofilm formation is also linked to the QS
mechanism [6]. In P. aeruginosa, QS consists of two
separate cascades, las and rhl, consisting of regulatory
(R) proteins, LasR and RhlR, and inducer (I) proteins,
LasI and RhlI, respectively. The I proteins synthesize
the corresponding signaling molecules (called autoin-
ducers [AIs]), N-(3-oxododecanoyl)-L-homoserine lac-
tone (3OC12-L-HSL), and N-butanoyl-L-homoserine lac-
tone (C4-L-HSL), and these molecules bind the cognate
R proteins to activate the QS circuits (Figure 1A, X = L-
HSL) [7, 8]. There exists a regulation hierarchy within
this QS system in which the LasR-3OC12-L-HSL complex
*Correspondence: hsuga@rcast.u-tokyo.ac.jpregulates rhlR expression [9]. Since QS plays a central
role in governing the gene expression of various viru-
lence factors, controlling QS by means of interfering
with the binding of AIs with their respective R proteins
potentially offers a curative form of treatment [10–13].
To gain insights into the molecular interaction of the
AIs with their cognate R proteins and ultimately aid
rational design of QS inhibitors, a study encompassing
synthesis and testing of a library of AI analogs was per-
formed earlier in our laboratory [14–16]. Our approach
for designing the AI library involved substitution of the
HSL moiety, which is a common structural element of
AIs in many gram-negative bacteria, with various
amines. Our study has identified several hits that act as
agonist or antagonist for the P. aeruginosa QS circuits.
Among them, the 3OC12 derivative of trans-2-aminocy-
clohexanol (rac-1, in Figure 1B) effectively agonizes the
las circuit, whereas the C4 derivatives of trans-2-amino-
cyclohexanone (rac-3) and trans-2-aminocyclopenta-
none (rac-4) agonize the rhl circuit more so than that of
rac-1. Interestingly, neither the 3OC12 nor C4 AI analog
containing the substitution of trans-2-aminocyclopenta-
nol (rac-2, Figure 1B) was able to activate the corre-
sponding QS circuit. In order to advance our understand-
ing of the R protein environment, we dealt with various
stereoisomers of the synthetic agonists. Based on our
understanding that even small structural changes affect
the outcome of activity to a great extent, we reasoned
that altering stereochemistry of the synthetic agonists
would provide valuable insight into the stereoenviron-
ment of the QS regulators. To further assist in under-
standing the molecular interaction between synthetic
agonists and a QS regulator, LasR, we built an in silico
model of the LasR active site based on its homolog pro-
tein, TraR, and carried out docking studies for AI analogs.
Although the crystal structures for the P. aeruginosa QS
regulators are currently unavailable, this in silico model
of LasR has given us not only better understanding of
its molecular interaction with the AI analogs, but also
a foundation toward the rational design of novel agonists
and antagonists in the future.
Results and Discussion
Synthesis of Enantiomerically Pure AI Analogs
The requisite amino alcohols for the enantiomerically
pure form of trans-derivatives, (S,S)-1, (S,S)-2, (R,R)-1,
and (R,R)-2 (Figure 1C; note that 1 and 2 represent the
derivatives of aminocyclohexanol and cyclepentanol,
respectively, and that the first stereochemistry with S
is consistent with that of L-HSL), were synthesized by
a known strategy, consisting of a catalytic asymmetric
ring opening reaction of cyclohexene oxide and cyclo-
pentene oxide with Jacobsen’s catalyst (Figure S1; see
the Supplemental Data available with this article online)
[17]. The corresponding cis-amino alcohols, (S,R)-1,
(S,R)-2, (R,S)-1, and (R,S)-2, were obtained by inversion
of the hydroxyl group. These amino alcohols were then
coupled with the fatty acid side chains to obtain the
desired 3OC12 and C4 analogs (Figures S2 and S3).
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ducer and Autoinducer Analogs
(A) Structure of 3OC12 and the C4 side chain.
(B) Natural AI and AI analogs derived from ra-
cemic cyclohexanol/one and cyclopentanol/
one.
(C) AI analogs derived from enantiomerically
pure cyclohexanol/one and cyclopentanol/
one.The 2-aminocycloketone derivatives, (S)-3, (R)-3, (S)-4,
and (R)-4 (note that 3 and 4 represent the derivatives
of aminocyclohexanone and pentanone, respectively),
were synthesized by Dess-Martin oxidation of their hy-
droxyl derivatives (Figures S2 and S3) [18].
Agonist activity of these derivatives was tested by
their ability to induce the expression of green fluores-
cent protein (GFP) in P. aeruginosa reporter strains
PAO-JP2 (plasI-LVAgfp), for the 3OC12 analogs, and
PAO-JP2 (prhlI-LVAgfp), for the C4 analogs [19], in which
each QS system can be exogenously activated by the
addition of the synthetic AIs or analogs, correlating to
the level of GFP expression.
Activation of the las Circuit by Amino
Alcohol Derivatives
The 3OC12 derivatives of trans-aminocyclohexanol,
(S,S)-1 and (R,R)-1, and trans-aminocyclopentanol,
(S,S)-2and (R,R)-2, were tested for las activation. Among
these, 3OC12-(S,S)-1 exhibited the highest activity,
which was nearly comparable to the cognate AI,
3OC12-L-HSL (Figure 2A), while 3OC12-(R,R)-1 hadw2-
fold poorer activity than 3OC12-(S,S)-1. These results
are predicted to some extent based on the fact that the
natural 3OC12-L-HSL stimulates the las circuit more ef-
fectively than the unnatural 3OC12-D-HSL [20]. Despite
the predicted stereochemical preference, the observed
difference in activity between 3OC12-L-HSL and 3O12-
D-HSL is much larger than that between derivatives of
(R,R)-1 and (S,S)-1 (Figure S5). This indicates that LasR
more severely discriminates the stereochemistry of
HSL than that of the analog. On the other hand, both ste-
reoisomers of trans-aminocyclopentanol were nearly in-
active (Figure 2B), suggesting that presentation of the
amide and hydroxyl groups in the trans-aminocyclopen-
tanol derivatives to the stereoenvironment in the LasR li-
gand binding site differs from that of the trans-aminocy-
clohexanol derivatives.
Interestingly, LasR responded to the cis-isomers with
a different stereochemical preference than the trans-
isomers (Figure 2A). Unlike the observation for the
trans-isomers of aminocyclohexanol, the (R,S)-1 deriva-
tive bearing the opposite stereochemistry to L-HSL
showed slightly higher agonist activity than the (S,R)-1
derivative. On the other hand, in the case the cis-amino-
cyclopentanols, 3OC12-(S,R)-2 shows agonist activity(Figure 2B). This result is prominent since, among the
four aminocyclopentanol derivatives tested, only the
(S,R)-2 derivative exhibited observable agonist activity
at concentrations below 50 mM (Figure S4). Although
none of these compounds were as active as 3OC12-
(S,S)-1, these results seem to indicate that the agonist
activity depends on the ring scaffold in which the projec-
tion of the amide and hydroxyl groups is appropriate for
the interaction with the residues in LasR.
Activation of the rhl Circuit by Amino
Alcohol Derivatives
The trends for the agonist activity of the C4-aminocyclo-
hexanol derivatives for the rhl circuit correlated with
those for the las circuit. Among these analogs, only C4-
(S,S)-1 exhibits significant agonist activity, and others
show modest (C4-(R,S)-1) or poor activity (Figure 2C).
Two noteworthy observations were made in this series
of studies for the cyclohexanol derivatives. First, this
study has revealed that C4-(S,S)-1 acts as an effective
rhl agonist, whereas its enantiomer, C4-(R,R)-1, is
a poor agonist. The observed difference in activity be-
tween these two C4 trans-enantiomers is more pro-
nounced than that between 3OC12 trans-enantiomers
(Figure 2C versus Figure 2A), somewhat similar to the
observation of 3OC12-L-HSL versus 3OC12-D-HSL [20].
Second, in the case of cis-isomers, C4-(R,S)-1 is modest
but clearly active, while C4-(S,R)-1 is inactive, in contrast
to the observed trend of their trans-derivatives as dis-
cussed above. Thus, it is clear that, in the case of cis-
cyclohexanol derivatives, those with the reversed ste-
reochemistry of the amide group show higher activity
than the natural configuration.
We also synthesized and tested a series of C4-amino-
cyclopentanol derivatives, stereoisomers of C4-2, for the
rhl circuit activation (Figure 2D). These four stereoiso-
mers exhibited modest, but a somewhat similar degree
of, rhl agonist activity. This is in sharp contrast to the
observation that 3OC12-2 derivatives exhibited a signifi-
cant difference in the ability to activate the las circuit, in
which three out of four molecules are inactive (Figure 2B).
Activation of las and rhl Circuits by Amino
Ketone Derivatives
Lastly, a set of AI analogs consisting of amino ketone
derivatives 3 and 4 was tested. Neither the 3OC12
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125Figure 2. Agonist Activity of Cyclohexanol and Pentanol Derivatives
(A–D) (A) 3OC12-cyclohexanol derivatives for the las circuit. (B) 3OC12-cyclopentanol derivatives for the las circuit. (C) C4-cyclohexanol for the
rhl circuit. (D) C4-cyclopentanol derivatives for the rhl circuit. The level of GFP expression (relative fluorescence [a.u.]) was monitored by using
a molecular imager and was normalized to cell density by dividing the optical density (OD) at a wavelength of 600 nm. The standard deviation
was derived from results of four independent experiments. Assays for the las circuit, shown in (A) and (B), were carried out in the presence of
varying concentrations of the AI analogs, and those for the rhl circuit, shown in (C) and (D), were carried out in the presence of 1 mM 3OC12-L-
HSL as well as varying concentrations of the AI analogs. The middle of the error bar shown in each bar represents the mean score from four
independent experiments, and the error bar represents the standard deviation of all trials.derivatives of (S)/(R)-3 nor (S)/(R)-4 agonize the las cir-
cuit effectively (Figure 3A). In striking contrast, C4 deriv-
atives of the cyclic ketones exhibit high agonist activity
(Figure 3B), and this activity is dominated by the (S)-ste-
reoisomers. With these observations, it is clear that the
S configuration of the amide group in the C4-cyclic ke-
tones plays a dominant role in exhibiting agonist activity.
The above-described observations suggest that
though the HSL moiety of AIs is the common recognition
element for both LasR and RhlR, the microenvironment
of the binding site likely differs between LasR and RhlR.With this in mind, the similar conclusion can also be
derived from the observed difference in the studies of
the aminocyclopentanol derivatives and their cognate
circuits (Figure 2B versus Figure 2D); 3OC12-(S,S)-2
does not stimulate the las circuit at any concentration,
whereas C4-(S,S)-2 shows observable activity in the
stimulation of the rhl circuit. Moreover, LasR is only ac-
tive toward 3OC12-(S,R)-2; however, RhlR exhibits activ-
ity toward C4-(S,R)-2 and C4-(R,S)-2 at a similar level. All
of these results consistently suggest that despite the
fact that both LasR and RhlR recognize the HSL moietyFigure 3. Agonist Activity of Cyclic Ketone Derivatives
(A and B) (A) 3OC12-cyclohexanone derivatives for the las circuit. (B) C4-cyclohexanone for the rhl circuit. Assays for the las circuit, shown in
(A), were carried out in the presence of varying concentrations of the AI analogs, and those for the rhl circuit, shown in (B), were carried out in
the presence of 1 mM 3OC12-L-HSL as well as varying concentrations of the AI analogs. The middle of the error bar shown in each bar rep-
resents the mean score from four independent experiments, and the error bar represents the standard deviation of all trials.
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(A and B) (A) 3OC12-(S,S)-1 and (B) 3OC12-(S,S)-2 were docked to the modeled LasR ligand binding site. Docking was carried out by using the
FlexX program on the SYBYL interface. The residues displayed as balls-and-sticks are those involved in hydrogen bonding interactions (Y53,
W57, and D70; shown in blue) and those constituting the hydrophobic pocket (Y61, P71, T72, W85, F101, and F102; shown in green). The hy-
drophobic core is rendered as dots. The analogs (shown as capped sticks in violet) are superimposed over the structure of 3OC12-L-HSL (yel-
low line). Other residues in the ligand binding site are shown as green lines. The docked structures of 3OC12-L-HSL and 3OC12-(S,R)-2 are
included in the Supplemental Data.of the cognate AIs, the microenvironment of their bind-
ing sites is unlikely the same.
Docking Studies for the Natural AI
and Its Analogs for the las Circuit
In order to examine whether the observed activities of
the AI analogs correlated to their ability for accommoda-
tion to the ligand binding site, we decided to build an in
silico model of the ligand binding site. The screening
method utilizing the GFP reporter strain allowed for
rapid screening of the analogs for the activation of their
respective QS circuits, and docking these analogs in the
modeled binding site would provide an understanding of
their interactions with the microenvironment at the li-
gand binding site. We based our model on the available
crystal structure of TraR (PDB code: 1L3L) from Agro-
bacterium tumefaciens complexed with its AI and DNA
[21, 22], the only available structure of a LuxR homolog.
Neither isolation nor expression of active LasR or RhlR
has been successful so far. Therefore, these are the
only structural data that allow us to build virtual struc-
tures of the P. aeruginosa R proteins.
TraR AI, 3OC8-HSL with a 3-oxo group, is structurally
more similar to LasR AI, 3OC12-L-HSL with a 3-oxo
group, than to RhlR AI, C4-L-HSLwithout a 3-oxo group.
We therefore speculated that the docking studies of
LasR-agonist pairs would give us a more reliable predic-
tion for the interaction of the residues with HSL or its an-
alog, and we chose the LasR-agonist pairs for the dock-
ing studies. Based on protein sequence alignment of
LasR and TraR with ClustalW (Table S1 and Figure S6)
[23], the amino acid residues in TraR were replaced
with the appropriate ones to construct the in silico model
for the LasR AI binding site (Figure S7C). The ligands
were docked into the modeled site by using FlexX [24]
as the docking program, and scores were computed.
The docking results correlated well with our experi-
mental data (Figures S7A and S7B). The study compar-
ing the activity of the trans-aminocyclohexanol andtrans-aminocyclopentanol derivatives indicated that
some additional factor other than stereochemistry
played a role in the higher activity of (S,S)-1, compared
to no activity in the case of (S,S)-2 (Figure 4A versus
Figure 4B). Docking suggested that, in the case of
(S,S)-1, the cyclohexyl ring deeply penetrates in the hy-
drophobic pocket, and that the hydroxyl group of (S,S)-1
maintains a hydrogen bonding interaction similar to that
of the carbonyl group of HSL (see also Figure S7C). A
combination of the hydrophobic contacts and a hydro-
gen bonding interaction probably make 3OC12-(S,S)-1
a strong agonist. The lesser activity of the opposite ste-
reoisomer, 3OC12-(R,R)-1, can be explained based on
the fact that, though the hydrophobic contacts are main-
tained, the hydroxyl group flips to the opposite side
upon accommodation of the reversed stereogenic cen-
ter to the ligand binding site (data not shown). In the
case of 3OC12-(S,S)-2, it appears that the placement of
the cyclopentyl ring in a slightly tilted position relative
to the HSL ring might serve to maintain the hydrogen
bonding interactions with W57 (Figure 4B). This may re-
sult in loss of interactions with the hydrophobic surface
and therefore loss of the agonist activity. Thus, it seems
that hydrophobic contacts contribute to a greater extent
in governing the activity.
Next, the explanation for the activity of the cis-isomer,
3OC12-(S,R)-2, compared to the inactive trans-isomer,
3OC12-(S,S)-2, was sought. Docking of 3OC12-(S,R)-2
to the ligand binding site showed that the cyclopentyl
ring penetrates the hydrophobic pocket in a manner
similar to that observed for 3OC12-(S,S)-1 (Figure S7C
versus Figure S7D), compared to the tilted accommoda-
tion of 3OC12-(S,S)-2 (Figure 4B). The modest activity of
3OC12-(S,R)-2 is probably due to the extended distance
and hence the weakened hydrogen bonding interaction
between the hydroxyl group and W57.
Our docking studies agreed well with the experimental
data (Figures S7A and S7B), but a shortcoming of our
approach should also be mentioned. Since the
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mutations of a homolog protein (TraR) as described (Ta-
ble S1 and Figure S6), the hydrophobic interactions in
the fatty acid binding site consisting of many of these
residues could not be well defined. Because of this un-
known contribution from such ambiguously defined in-
teractions to ligand binding, we intentionally excluded
them from the free energy estimation. However, since
all agonists share the same 3O-C12 fatty acid chain,
and since positioning of the amide group was not dras-
tically different among the docking models, we believe
that our simulations could generate a meaningful expla-
nation of the observed strength of agonist binding.
In conclusion, our docking studies gave us critical in-
sight into the LasR-agonist interaction. The combination
of the hydrophobic interaction of the hydrocarbon ring
and hydrogen bonding interaction with the hydroxyl
group on the ring is a critical determinant for agonist
activity. 3OC12-(S,S)-1 acts as a strong agonist, because
both interactions are maintained better than the other
two analogs tested for the docking studies. Its cyclo-
hexyl ring deeply penetrates into the hydrophobic
pocket to maximize the hydrophobic interaction, and,
also, the (S,S)-stereochemistry of the hydroxyl and
amide groups allows for maintenance of the hydrogen
bonding with W57, D70, and Y53. Based on the results
observed for the aminoacyclopentanol derivatives, we
suggest that the extended hydrophobic interaction plays
a more crucial role in binding than the hydrogen bonding
interaction with W57. Such information would be useful
for rational design of molecules that antagonize the QS
circuits in the future.
Significance
The key for designing antagonists for theQS regulators
lies in understanding the regulatory protein environ-
ment. With this intention, we probed the protein envi-
ronment with a series of enantiomerically pure deriva-
tives of the autoinducer analogs. One of the striking
findings here is that, depending on the ring structure,
the appropriate combination of absolute and relative
stereochemistries of the amide and hydroxyl groups
dictates the exhibition of agonist activity. In addition,
the docking studies shed light on the contribution of
the hydrophobic residues and specific hydrogen bond-
ing interactions in determining the outcome of activity.
The inputs gained from this study would provide both
stereochemical and structural considerations for the
design of potent agonists and antagonists.
Experimental Procedures
Abbreviations
LiOHH2O, lithium hydroxide monohydrate; THF, tetrahydrofuran;
EDCI, 1-(3-dimethylaminopropyl)-3-ethyl-carbodiimidehydrochlo-
ride; DMAP, dimethylamino-pyridine; L-HSL, L-homoserine lactone;
DMF, dimethyl formamide; iPr2NEt, diisopropylethylamine; TEA,
triethylamine; n-BuLi, n-butyl lithium; p-TsOH, p-toluene sulphonic
acid; TFA, trifluroacetic acid.
Synthesis of the Natural Autoinducers
The natural AIs, 3OC12-L-HSL and C4-L-HSL, were prepared ac-
cording to published procedures. All analytical data were consistent
with those in the literature.Synthesis of 2-Amino Cyclic Alcohols
2-Amino cyclic alcohols ((S,S)-1, (S,R)-1, (R,R)-1, (R,S)-1, (S,S)-2,
(S,R)-2, (R,R)-2, and (R,S)-2) were prepared according to published
procedures, as shown in Figure S1. The analytical data for all inter-
mediate and final compounds were consistent with those in the
literature.
Synthesis of Autoinducer Analogs
General Synthetic Procedures of 3OC12 Derivatives
of 2-Aminocyclohexanol or Pentanol
3,3-ethylenedioxydodeca-noic acid (see Figure S2) was prepared
according to the procedures previously reported [7]. It was then cou-
pled with the corresponding 2-aminocyclohexanol ((S,S)-1, (S,R)-1,
(R,R)-1, or (R,S)-1) or 2-aminocyclopentanol ((S,S)-2, (S,R)-2, (R,R)-
2, or (R,S)-2) in the presence of EDCI, DMAP, and iPr2EtN in DMF
according to the procedures previously reported. The obtained
molecule was treated with TFA in CH2Cl2 to remove the cyclic ketal
protective group, followed by purification on silica gel, resulting in
the desired AI analogs in anw75%–85% yield. All characterizations
are included in the Supplemental Data. See more detailed proce-
dures in [14] and [15].
General Synthetic Procedures of 3OC12 Derivatives
of 2-Aminocyclohexanone or Pentanone
N-[2-hydroxycyclohexyl]-(3,3-ethylenedioxy)-dodecanamide was
treated with 1.1 equivalents of Dess-Martin periodinane in CH2Cl2
[18], followed by TFA deprotection to give the desired 3OC12 deriva-
tives of (S)- or (R)-2-aminocyclohexanone or pentanone in anw65%–
75% yield (Figure S2). See more detailed procedures in [14] and [15].
General Synthetic Procedures of C4 Derivatives
of 2-Aminocyclohexanol or Pentanol
and 2-Aminocyclohexanone or Pentanone
Butyryl chloride was coupled with the corresponding 2-aminocyclo-
hexanol or pentanol to give the C4 derivative of (S,S)-1, (S,R)-1, (R,R)-
1, (R,S)-1, (S,S)-2, (S,R)-2, (R,R)-2, or (R,S)-2, according to the proce-
dures previously reported (yield of 80%–85%) (Figure S3). The C4-
amino alcohol derivatives were treated with Dess-Martin periodinane
to give the desired cyclic ketone derivatives in anw70%–75% yield.
Procedure for Reporter Strain Assays
The reporter strains PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlI-
LVAgfp) were grown overnight in CIRCLEGROW (Bio101, Inc.) media
containing 300 mg/ml and 100 mg/ml carbenicellin, respectively, at
37ºC and were diluted to an OD600 of 0.1. After incubation for 1 hr,
200 ml cell culture was added to individual wells of a 96-well plate
containing the desired analogs to be tested. All derivatives and syn-
thetic autoinducers were added to wells as solutions in chloroform;
the wells were thoroughly dried before addition of cell culture. For
the las circuit, concentrations ranging from 1 to 200 mM 3OC12-L-
HSL were added in the control wells. The individual analogs were
added to separate wells in the same concentration range. For the
rhl circuit, control wells consisted of 1 mM 3OC12-L-HSL in addition
to varying concentrations of C4-L-HSL ranging from 1 to 200 mM.
In the test wells, individual analogs were added to separate wells
along with 1 mM 3OC12-L-HSL. The plates were incubated for 6 hr
with shaking at 37ºC and were scanned for fluorescence emission
by using a BIORAD Molecular Imager (488 nm excitation and 695
nm bandpass filter). The level of GFP expression (relative fluores-
cence [a.u.]) was quantified by using ImageQuant software and
was normalized to cell density by dividing the optical density (OD)
at a wavelength of 600 nm. The standard deviation was derived
from results in four independent experiments.
Supplemental Data
Supplemental Data including figures for synthesis, characteriza-
tions, experimental details for a reporter strain assay, a table of mod-
ified residues for the LasR model, and docking studies for 3OC12-L-
HSL and its analogs are available at http://www.chembiol.com/cgi/
content/full/13/2/123/DC1/.
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